Lincoln Pharmaceuticals Share Price
620.80-1.85 (-0.30%)
+11.77% past 1 Year
News
Lincoln Pharma targets Rs 1,000 crore revenue in three years
Equity
LINCOLN
Lincoln Pharma reports flat EBITDA margin with higher quarterly EBITDA
Equity
LINCOLN
Lincoln Pharma reports higher Q1 revenue at Rs 177 crores
Equity
LINCOLN
Lincoln Pharma reports higher Q1 net profit on yearly basis
Equity
LINCOLN
Lincoln Pharma Q4 EBITDA declines year-on-year with margin compression reported
Equity
LINCOLN
Lincoln Pharma posts flat Q4 profit with healthy double-digit revenue growth
Equity
LINCOLN
Lincoln Pharma reports Profit after tax of 11.63 Crores, in the March 2026 quarter
Equity
LINCOLN
Lincoln Pharma - Quaterly Results
Equity
LINCOLN
Lincoln Pharma reports Profit after tax of 28.60 Crores, in the December 2025 quarter
Equity
LINCOLN
Lincoln Pharmaceuticals Q3 EBITDA Slightly Down YoY at Rs 23.60 Crores, Margin Contracts to 14.2%
Equity
LINCOLN
Lincoln Pharmaceuticals Q3 FY26 Revenue Growth YoY at 12.6%
Equity
LINCOLN
Lincoln Pharmaceuticals Q3FY26 Net Profit Rises 37.5% YoY to Rs 28.60 Crores.
Equity
LINCOLN
Lincoln Pharma reports Profit after tax of 19.98 Crores, in the September 2025 quarter
Equity
LINCOLN
Lincoln Pharmaceuticals Q2 FY25 net profit declines to Rs 20 crore versus Rs 26.3 crore YoY.
Equity
LINCOLN
Lincoln Pharmaceuticals Q2 FY26 reports lower EBITDA and margin compared to previous year.
Equity
LINCOLN
Lincoln Pharmaceuticals informs about press release
Equity
LINCOLN
Lincoln Pharmaceuticals informs about AGM
Equity
LINCOLN
Lincoln Pharma - Quaterly Results
Equity
LINCOLN
Lincoln Pharma - Quaterly Results
Equity
LINCOLN
Lincoln Pharma reports Profit after tax of 27.68 Crores, in the June 2025 quarter
Equity
LINCOLN